strontium-89

strontium-89

Radiation oncology A beta-emitting bone-seeking radioisotope–T1⁄2 50.4 days, used to manage pain in Pts with diffuse bone metastases–eg, with end-stage breast or prostate CA for whom pain medication may be ineffective